AMSTERDAM & WASHINGTON, DC – September 26, 2013 – The HOOKVAC consortium, led by the Academic Medical Center (AMC) at the University of Amsterdam, today announced it has been awarded a grant of six million Euros from the European Commission FP7 programme to expand the Sabin Vaccine Institute Product Development Partnership’s (Sabin PDP) work to develop and test a vaccine for human hookworm, a disease that infects 600-700 million of the world’s poorest people. Under this grant, the HOOKVAC consortium, which includes partners from the European Union, United States and Africa, will begin the first clinical testing of the human hookworm vaccine in the West African nation of Gabon.
September 3, 2013
Baylor College of Medicine
Program intends to develop and test a vaccine against all four major parasitic worm infectio
Op-ed by Tsutomu Takeuchi and Alvaro Arzú Irigoyen in the Huffington Post:
Posted: 06/11/2013 10:49 am
Whereas most people think about the NTDs as exclusive to destabilized countries such as South Sudan, Somalia, or Haiti, my recent analysis, published in Foreign Policy, has found that most of the world’s NTDs paradoxically occur in G20 countries in addition to Nigeria.